The Complement-based Drug Development Summit is the first industry-dedicated meeting that focuses on the research and development of therapeutics to inhibit the complement pathway, providing safe and effective cures for a range of disease indications. Across 3 content-packed days, the field's thought leaders from Alexion, True North, GSK, Alnylam and many more will be sharing their insight and lessons learned, collectively enabling the community to. URLs: Booking: https://go.evvnt.com/140307-3 Tickets: https://go.evvnt.com/140307-4 Price: Industry Workshop Only: USD 699 Industry Gold: Conference and 2 workshops: USD 3797 Speakers: Ted Yednock, Michael Holers, Camille Bedrosian, Eva-Maria Nichols, Sandip Panicker, Nader Najafian, Cedric Francois, Michael McCaleb, Niels Riedemann Time: 8:00 am to 6:00 pm Venue details: Hyatt Regency Boston, One Avenue de Lafayette, Boston, 02111, United States